|
FY2025
12 months to Sep 27, 2025
|
FY2024
12 months to Sep 28, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 24, 2022
|
FY2021
12 months to Sep 25, 2021
|
|
|---|---|---|---|---|---|
| Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances | |||||
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation expense | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Vendor non-trade receivables | |||||
| Inventories | |||||
| Other current and non-current assets | |||||
| Accounts payable | |||||
| Other current and non-current liabilities | |||||
| Cash generated by operating activities | |||||
| Investing activities: | |||||
| Purchases of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Proceeds from sales of marketable securities | |||||
| Payments for acquisition of property, plant and equipment | |||||
| Other | |||||
| Cash generated by investing activities | |||||
| Financing activities: | |||||
| Payments for taxes related to net share settlement of equity awards | |||||
| Payments for dividends and dividend equivalents | |||||
| Repurchases of common stock | |||||
| Proceeds from issuance of term debt, net | |||||
| Repayments of term debt | |||||
| Proceeds from/(Repayments of) commercial paper, net | |||||
| Other | |||||
| Cash used in financing activities | |||||
| Increase/(Decrease) in cash, cash equivalents, and restricted cash and cash equivalents | |||||
| Cash, cash equivalents, and restricted cash and cash equivalents, ending balances | |||||
| Supplemental cash flow disclosure: | |||||
| Cash paid for income taxes, net | |||||
| Cash paid for interest | |||||
Loading...